BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 11348869)

  • 1. Retinoids inhibit proliferation of human coronary smooth muscle cells by modulating cell cycle regulators.
    Wakino S; Kintscher U; Kim S; Jackson S; Yin F; Nagpal S; Chandraratna RA; Hsueh WA; Law RE
    Arterioscler Thromb Vasc Biol; 2001 May; 21(5):746-51. PubMed ID: 11348869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Doxazosin inhibits retinoblastoma protein phosphorylation and G(1)-->S transition in human coronary smooth muscle cells.
    Kintscher U; Wakino S; Kim S; Jackson SM; Fleck E; Hsueh WA; Law RE
    Arterioscler Thromb Vasc Biol; 2000 May; 20(5):1216-24. PubMed ID: 10807736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of vascular smooth muscle cell proliferation by sodium salicylate mediated by upregulation of p21(Waf1) and p27(Kip1).
    Marra DE; Simoncini T; Liao JK
    Circulation; 2000 Oct; 102(17):2124-30. PubMed ID: 11044431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver X receptor agonists suppress vascular smooth muscle cell proliferation and inhibit neointima formation in balloon-injured rat carotid arteries.
    Blaschke F; Leppanen O; Takata Y; Caglayan E; Liu J; Fishbein MC; Kappert K; Nakayama KI; Collins AR; Fleck E; Hsueh WA; Law RE; Bruemmer D
    Circ Res; 2004 Dec; 95(12):e110-23. PubMed ID: 15539633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A non-thiazolidinedione partial peroxisome proliferator-activated receptor gamma ligand inhibits vascular smooth muscle cell growth.
    Bruemmer D; Berger JP; Liu J; Kintscher U; Wakino S; Fleck E; Moller DE; Law RE
    Eur J Pharmacol; 2003 Apr; 466(3):225-34. PubMed ID: 12694805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transforming growth factor beta(1) selectively inhibits the cyclic AMP-dependent proliferation of primary thyroid epithelial cells by preventing the association of cyclin D3-cdk4 with nuclear p27(kip1).
    Depoortere F; Pirson I; Bartek J; Dumont JE; Roger PP
    Mol Biol Cell; 2000 Mar; 11(3):1061-76. PubMed ID: 10712520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The retinoic acid receptor antagonist, BMS453, inhibits normal breast cell growth by inducing active TGFbeta and causing cell cycle arrest.
    Yang L; Ostrowski J; Reczek P; Brown P
    Oncogene; 2001 Nov; 20(55):8025-35. PubMed ID: 11753686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parathyroid hormone-related protein induces G1 phase growth arrest of vascular smooth muscle cells.
    Stuart WD; Maeda S; Khera P; Fagin JA; Clemens TL
    Am J Physiol Endocrinol Metab; 2000 Jul; 279(1):E60-7. PubMed ID: 10893323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Arotinoid mofarotene (RO40-8757) up-regulates p21 and p27 during growth inhibition of pancreatic cancer cell lines.
    Kawa S; Nikaido T; Aoki Y; Zhai Y; Kumagaya T; Furihata K; Fujii S; Kiyosawa K
    Int J Cancer; 1997 Sep; 72(5):906-11. PubMed ID: 9311612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential regulation of p27kip1 levels and CDK activities by hypertrophic and hyperplastic agents in vascular smooth muscle cells.
    Rao GN
    Biochim Biophys Acta; 1999 Jan; 1448(3):525-32. PubMed ID: 9990305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disruption of the actin cytoskeleton leads to inhibition of mitogen-induced cyclin E expression, Cdk2 phosphorylation, and nuclear accumulation of the retinoblastoma protein-related p107 protein.
    Reshetnikova G; Barkan R; Popov B; Nikolsky N; Chang LS
    Exp Cell Res; 2000 Aug; 259(1):35-53. PubMed ID: 10942577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of the cyclin-dependent kinase inhibitors p27(Kip1), p21(Cip1), and p16(Ink4) on vascular smooth muscle cell proliferation.
    Tanner FC; Boehm M; Akyürek LM; San H; Yang ZY; Tashiro J; Nabel GJ; Nabel EG
    Circulation; 2000 May; 101(17):2022-5. PubMed ID: 10790340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p27(Kip1) is important in modulating pulmonary artery smooth muscle cell proliferation.
    Fouty BW; Grimison B; Fagan KA; Le Cras TD; Harral JW; Hoedt-Miller M; Sclafani RA; Rodman DM
    Am J Respir Cell Mol Biol; 2001 Nov; 25(5):652-8. PubMed ID: 11713109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelin-1 potentiates human smooth muscle cell growth to PDGF: effects of ETA and ETB receptor blockade.
    Yang Z; Krasnici N; Lüscher TF
    Circulation; 1999 Jul; 100(1):5-8. PubMed ID: 10393673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TZDs inhibit vascular smooth muscle cell growth independently of the cyclin kinase inhibitors p21 and p27.
    Hupfeld CJ; Weiss RH
    Am J Physiol Endocrinol Metab; 2001 Aug; 281(2):E207-16. PubMed ID: 11440895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinoic acid-mediated G1 arrest is associated with induction of p27(Kip1) and inhibition of cyclin-dependent kinase 3 in human lung squamous carcinoma CH27 cells.
    Hsu SL; Hsu JW; Liu MC; Chen LY; Chang CD
    Exp Cell Res; 2000 Aug; 258(2):322-31. PubMed ID: 10896783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local cyclin-dependent kinase inhibition by flavopiridol inhibits coronary artery smooth muscle cell proliferation and migration: Implications for the applicability on drug-eluting stents to prevent neointima formation following vascular injury.
    Jaschke B; Milz S; Vogeser M; Michaelis C; Vorpahl M; Schömig A; Kastrati A; Wessely R
    FASEB J; 2004 Aug; 18(11):1285-7. PubMed ID: 15180955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of vascular smooth muscle cell growth by magnesium-role of mitogen-activated protein kinases.
    Touyz RM; Yao G
    J Cell Physiol; 2003 Dec; 197(3):326-35. PubMed ID: 14566962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential control of cyclins D1 and D3 and the cdk inhibitor p27Kip1 by diverse signalling pathways in Swiss 3T3 cells.
    Mann DJ; Higgins T; Jones NC; Rozengurt E
    Oncogene; 1997 Apr; 14(15):1759-66. PubMed ID: 9150381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peroxisome proliferator-activated receptor gamma ligands inhibit retinoblastoma phosphorylation and G1--> S transition in vascular smooth muscle cells.
    Wakino S; Kintscher U; Kim S; Yin F; Hsueh WA; Law RE
    J Biol Chem; 2000 Jul; 275(29):22435-41. PubMed ID: 10801895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.